<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01191710</url>
  </required_header>
  <id_info>
    <org_study_id>ProgRise001</org_study_id>
    <nct_id>NCT01191710</nct_id>
  </id_info>
  <brief_title>Progesterone Rise in Agonist Versus Antagonist in Vitro Fertilization (IVF) Cycles</brief_title>
  <official_title>Is the Clinical Outcome Affected by the Incidence of Progesterone Elevation on the Day of hCG Triggering When Agonist Protocol is Compared to Antagonist Protocol for IVF</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitair Ziekenhuis Brussel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>BioGenesis</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitair Ziekenhuis Brussel</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim is to explore whether the incidence of progesterone rise in the late follicular phase
      differs between GnRH-agonist and GnRH-antagonist protocols for IVF and whether this has an
      impact on the probability of pregnancy achievement.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In view of the current debate concerning possible differences in efficacy between the two
      GnRH analogues, the current study aimed to explore whether progesterone control in the late
      follicular phase differs when GnRH-agonist is used as compared to GnRH-antagonist and if so
      to what extend does the progesterone rise have an impact on the probability of achieving a
      pregnancy.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>January 2007</start_date>
  <completion_date type="Anticipated">January 2011</completion_date>
  <primary_completion_date type="Anticipated">January 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of late progesterone rise on the day of HCG triggering</measure>
    <time_frame>Up to delivery (2010)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical pregnancy rate Delivery rate</measure>
    <time_frame>Up to delivery (2010)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Pregnancy Outcome After In Vitro Fertilization (IVF)</condition>
  <arm_group>
    <arm_group_label>Antagonist group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Antagonist protocol for IVF</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Agonist group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Long Agonist protocol for IVF</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>In vitro fertilization</intervention_name>
    <description>In vitro fertilization procedure with gonadotropin induced follicular ovarian stimulation</description>
    <arm_group_label>Antagonist group</arm_group_label>
    <arm_group_label>Agonist group</arm_group_label>
    <other_name>IVF</other_name>
    <other_name>pregnancy</other_name>
    <other_name>embryo-transfer</other_name>
    <other_name>progesterone</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &lt; 39

          -  follicle-stimulating hormone (FSH) &lt; 12

          -  gonadotropin dose 100-300IU

        Exclusion Criteria:

          -  endometriosis

          -  known endocrine disorder

          -  blood analyzed in another laboratory
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>39 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Basil Tarlatzis, MD</last_name>
    <role>Study Chair</role>
    <affiliation>BioGenesis</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Biogenesis</name>
      <address>
        <city>Thessaloniki</city>
        <state>Pylaia</state>
        <zip>55536</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <link>
    <url>http://www.hrg.gr</url>
  </link>
  <reference>
    <citation>Papanikolaou EG, Kolibianakis EM, Pozzobon C, Tank P, Tournaye H, Bourgain C, Van Steirteghem A, Devroey P. Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer. Fertil Steril. 2009 Mar;91(3):949-52. Epub 2007 Jun 6.</citation>
    <PMID>17555751</PMID>
  </reference>
  <verification_date>January 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 27, 2010</study_first_submitted>
  <study_first_submitted_qc>August 30, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 31, 2010</study_first_posted>
  <last_update_submitted>September 14, 2010</last_update_submitted>
  <last_update_submitted_qc>September 14, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 15, 2010</last_update_posted>
  <responsible_party>
    <name_title>Papanikolaou Evangelos</name_title>
    <organization>Human Reproduction and Genetics Foundation (HRG)</organization>
  </responsible_party>
  <keyword>progesterone</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Progesterone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

